1st Day of Advent...

Wishing all our wonderful supporters a fabulous Christmas!

Listen to our late President and Co-founder Tom Isaacs' rendition of 'The First Day of Christmas...'

The_First_Day_of_Xmas.mp3

See our Christmas advent here.

Latest

The GDNF Trial - the facts
**Webinar** - Sleep and Parkinson’s Disease

Join the fourth instalment of our quarterly Parkinson’s webinar series in partnership with Journal of Parkinson’s Disease and Parkinson’s Movement as we discuss the topic ‘Sleep and Parkinson’s Disease’.
Tribute to Jon Hiseman Concert

On Saturday 2nd February, family, friends and stars of the legendary jazz-rock pioneers Colosseum came together at the O2 Shepherd's Bush Empire for a wonderful memorial concert celebrating the life and work of Jon Hiseman, a friend and supporter of CPT for many years.
The European Journal of Neuroscience - Special 'Tom Isaacs' Edition

This Special Issue of the European Journal of Neuroscience has been put together by NECTAR (the Network for European CNS Transplantation & Restoration) in collaboration with The Cure Parkinson's Trust in memory of the late Tom Isaacs who sadly passed away suddenly in May 2017.

24th Day of Advent - It's Christmaaaasss!

Well... what an inspiring year! A huge and heartfelt thank you to everyone for being part of it...
23rd Day of Advent

Looking back over the year, we’ve showcased a few more fantastic fundraising events taken on by our wonderful individual fundraisers...
22nd Day of Advent

Scientists at the MRC Centre for Regenerative Medicine (University of Edinburgh)- led by Dr Tilo Kunath and part-funded by The Cure Parkinson's Trust (CPT) - have published a research report demonstrating that genetically reducing alpha synuclein, using gene editing, results in a measure of resistance to one of the pathological hallmarks of Parkinson's.
21st Day of Advent

In November we reported on a team of investigators who had blocked neuron death by treating the affected neurons with a repurposed medicine already available in the form of 'PARP1 inhibitors'. In models of Parkinson's, this treatment not only reduced levels of alpha synuclein, but also prevented the loss of dopamine neurons.
20th Day of Advent

This year CPT was delighted to be the beneficiary charity of both the 30th Anniversary Gulls' Eggs and the Grouse & Grape Luncheons.
19th Day of Advent

CPT in association with Bonhams and Artwise were thrilled to be part of the second edition of Cure3 in October, an acclaimed selling exhibition devised to raise awareness and funds for Parkinson’s research.
18th Day of Advent

In September we announced the winners of the Tom Isaacs Award...
17th Day of Advent

In September, our Linked Clinical Trials committee met for the sixth year running - a pioneering collaborative meeting of many of the world's leading Parkinson's authorities, to discuss fast tracking potential drugs for repurposing in Parkinson's ...
16th Day of Advent

This year we have seen so many amazing individuals set themselves inspiring running challenges in support of CPT including…
15th Day of Advent

In August, CPT was delighted to announce that the R S MacDonald Charitable Trust awarded a grant to co-fund the continuing dopamine replacement stem cell research of Dr Tilo Kunath in Edinburgh...

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Stem Cell Therapies - Research Updates

When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

The Annual Review 2018

Our Annual Review 2018 - your online publication here... Read more

Parkinson's Movement

The Science of Parkinson's - Dr Simon Stott

Leave a gift in your Will

A donation to The Cure Parkinson's Trust will make a huge difference to our research to slow, stop or even reverse Parkinson's. Read more